Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters appied:
Tag
close icon
Sort by
13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants.
Federico Martinón-Torres, Hanna Czajka, Kimberly J. Center, Jacek Wysocki, Ewa Majda-Stanislawska, Felix Omeñaca, Enrique Bernaola Iturbe, Daniel Blazquez Gamero, Ana Concheiro-Guisán, Francisco Gimenez-Sanchez, Leszek Szenborn, Peter C. Giardina, Scott Patterson, William C. Gruber, Daniel A. Scott, Alejandra Gurtman
Journal:
Pediatrics
Publicación independiente
Impact factor
5.359
Q1
Year:
2015
Doi:
https://doi.org/10.1542/peds.2014-2941
Vaccine evaluation: lessons from a meningococcal B vaccine.
Sarfatti A, Martinón-Torres F, Nadel S
Journal:
Arch Dis Child
Publicación independiente
Impact factor
3.041
Q1
Year:
2015
Doi:
https://doi.org/10.1136/archdischild-2014-306030
Should the Indication of Pneumococcal Polysaccharide Vaccine in Children Be Definitively Withdrawn?
Federico Martinón Torres
Journal:
Clin Infect Dis
Publicación independiente
Impact factor
8.313
Q1
Year:
2014
Doi:
https://doi.org/10.1093/cid/ciu228
Rotavirus vaccination in Europe: drivers and barriers.
N Parez, C Giaquinto, C Du Roure, F Martinon-Torres, V Spoulou, P Van Damme, T Vesikari
Journal:
Lancet Infect Dis
Publicación independiente
Impact factor
24.446
Q1
Year:
2014
Doi:
https://doi.org/10.1016/S1473-3099(14)70035-0
RSV—Still More Questions Than Answers
Louis Bont, Eugenio Baraldi, Brigitte Fauroux, Anne Greenough, Terho Heikkinen, Paolo Manzoni, Federico Martinón-Torres, Harish Nair and Nikolaos G. Papadopoulos, on behalf of ReSViNET
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q2
Year:
2014
Doi:
https://doi.org/10.1097/INF.0000000000000535
Prognostic markers of meningococcal disease in children: recent advances and future challenges.
María Montero-Martín, David P Inwald, Enitan D Carrol & Federico Martinón-Torres
Journal:
Expert Rev Infect Ther
Publicación independiente
Impact factor
3.767
Q1
Year:
2014
Doi:
https://doi.org/10.1586/14787210.2014.966079
Pneumococcal Vaccination in Europe: Schedule Adherence
Alain Gervaix; Filippo Ansaldi; Antonio Brito-Avô; Chiara Azzari, Markus Knuf; Federico Martinón-Torres; David Tuerlinckx; Myint TinTin Htar, and George A. Syrogiannopoulos
Journal:
Clin Therap
Publicación independiente
Impact factor
3.119
Q2
Year:
2014
Doi:
https://doi.org/10.1016/j.clinthera.2014.03.001
Overuse of bronchodilators and steroids in bronchiolitis of different severity Bronchiolitis-study of variability, appropriateness, and adequacy
C. Ochoa Sangrador, J. González de Dios, Research Group of the aBREVIADo Project
Journal:
Allergol Immunopathol (Madr)
Publicación independiente
Impact factor
1.276
Q3
Year:
2014
Doi:
Caracterización microbiológica de las gastroenteritis agudas virales atendidas en un servicio de pediatría en un área de alta cobertura vacunal frente a rotavirus
Carlos García-Magán, María José de Castro-López, José Llovo-Taboada, Carmen Curros-Novo, Miriam Puente-Puig, Alicia Sánchez-Fauquier, Federico Martinón-Torres
Journal:
Enferm Infecc Microbiol Clin
Publicación independiente
Impact factor
1.654
Q3
Year:
2014
Doi:
https://doi.org/10.1016/j.eimc.2013.09.008
Evolving Role of 13-valent Pneumococcal Conjugate Vaccine in Clinical Practice
Azzari C, Martinón-Torres F, Schmitt HJ, Dagan R.
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q2
Year:
2014
Doi:
https://doi.org/10.1097/INF.0000000000000328
Evaluating the accuracy of AIM panels at quantifying genome ancestry
Jacobo Pardo-Seco, Federico Martinón-Torres and Antonio Salas
Journal:
BMC Genomics
Publicación independiente
Impact factor
3.594
Q2
Year:
2014
Doi:
https://doi.org/10.1186/1471-2164-15-543
Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome
Jan De Waele, Jeffrey Lipman, Yasser Sakr, John C Marshall, Philippe Vanhems, Casiano Barrera Groba, Marc Leone, Jean-Louis Vincent and for the EPIC II Investigators
Journal:
BMC Infec Dis
Publicación independiente
Impact factor
2.688
Q3
Year:
2014
Doi:
Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study
Thierry Gustot, Peter Felleiter, Peter Pickkers, Yasser Sakr, Jordi Rello, Dimitrios Velissaris, Charalampos Pierrakos, Fabio S. Taccone, Pavel Sevcik, Christophe Moreno, Jean-Louis Vincent and for the EPIC II Group of Investigators
Journal:
Liver Internat.
Publicación independiente
Impact factor
5.175
Q1
Year:
2014
Doi:
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants.
Federico Martinon-Torres, Francisco Gimenez-Sanchez, Enrique Bernaola-Iturbe,Javier Diez-Domingo, Qin Jiang, John L. Perez
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Year:
2014
Doi:
https://doi.org/10.1016/j.vaccine.2014.07.049
Fe de errores de «Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes»
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinon-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel, J.A. Vázquez
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
Year:
2014
Doi:
https://doi.org/10.1016/j.anpedi.2014.02.015
A Genome-Wide Study of Modern-Day Tuscans: Revisiting Herodotus’s Theory on the Origin of the Etruscans
Jacobo Pardo-Seco, Alberto Gómez-Carballa, Jorge Amigo, Federico Martinón-Torres, Antonio Salas
Journal:
PLoS ONE
Publicación independiente
Impact factor
2.740
Q2
Year:
2014
Doi:
https://doi.org/10.1371/journal.pone.0105920
Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinon-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel, J.A. Vázquez
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
Year:
2014
Doi:
https://doi.org/10.1016/j.anpedi.2013.04.013
Immunisation against meningococcus B: the case of Spain
Federico Martinón Torres
Journal:
Lancet
Publicación independiente
Impact factor
60.392
Q1
Year:
2013
Doi:
https://doi.org/10.1016/S0140-6736(13)62323-5
Read my lips: oral manifestations of systemic diseases.
de Castro López MJ, Illade Quinteiro L, Martinón Torres F, Cutrín Prieto JM.
Journal:
Journal of Pediatrics
Publicación independiente
Impact factor
3.700
Q1
Year:
2013
Doi:
https://doi.org/10.1016/j.jpeds.2013.06.080
Dr. Google: what about the human papillomavirus vaccine?
Leticia Pías-Peleteiro, Javier Cortés-Bordoy, and Federico Martinón-Torres
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
Year:
2013
Doi:
https://doi.org/10.4161/hv.25057
Adaptive support ventilation: State of the art review.
Fernández J, Miguelena D, Mulett H, Godoy J, Martinón-Torres F.
Journal:
Indian J Crit Care Med
Publicación independiente
Impact factor
Year:
2013
Doi:
https://doi.org/10.4103/0972-5229.112149
Indian Signatures in the Westernmost Edge of the European Romani Diaspora: New Insight from Mitogenomes
Alberto Gómez-Carballa, Jacobo Pardo-Seco, Laura Fachal, Ana Vega, Miriam Cebey, Nazareth Martinón-Torres, Federico Martinón-Torres, Antonio Salas
Journal:
PLoS ONE
Publicación independiente
Impact factor
2.740
Q2
Year:
2013
Doi:
https://doi.org/10.1371/journal.pone.0075397
Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes.
Jethro A. Herberg, Myrsini Kaforou, Stuart Gormley, Edward R. Sumner, Sanjay Patel, Kelsey D. J. Jones, Stéphane Paulus, Colin Fink, Federico Martinon-Torres, Giovanni Montana, Victoria J. Wright, and Michael Levin
Journal:
J. Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2013
Doi:
https://doi.org/10.1093/infdis/jit348
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule
Gail L. Rodgersa, Susanna Esposito, Nicola Principi, Maricruz Gutierrez-Brito, Javier Diez-Domingo, Andrew J. Pollard, Matthew D. Snape,Federico Martinón-Torres, William C. Gruber, Scott Patterson, Allison Thompson,Alejandra Gurtman, Peter Paradiso, Daniel A. Scott
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Year:
2013
Doi:
https://doi.org/10.1016/j.vaccine.2013.08.009
No results found.
Vacunación frente a la hepatitis B. Impacto de los programas de vacunación tras 20 años de su utilización en España. ¿Es tiempo de cambios?
Javier Arístegui Fernándeza, Javier Díez-Domingo, Josep Marés Bermúdez, Federico Martinón Torres
Doi:
Enferm Infecc Microbiol Clin.
Factor de impacto:
Q3
Doi:
Viral Co-Infections in Pediatric Patients Hospitalized with Lower Tract Acute Respiratory Infections.
Miriam Cebey-López, Jethro Herberg, Jacobo Pardo-Seco, Alberto Gómez-Carballa, Nazareth Martinón-Torres, Antonio Salas, José María Martinón-Sánchez, Stuart Gormley, Edward Sumner, Colin Fink, Federico Martinón-Torres, GENDRES network
Doi:
PLoS ONE
Factor de impacto:
Q2
Doi:
The unbearable lightness of being heliox
Federico Martinón Torres
Doi:
Lancet
Factor de impacto:
Q1
Doi:
The Genomic Legacy of the Transatlantic Slave Trade in the Yungas Valley of Bolivia
Tanja Heinz, Jorge Mario Cárdenas, Vanesa Álvarez-Iglesias, Jacobo Pardo-Seco, Alberto Gómez-Carballa, Carla Santos, Patricia Taboada-Echalar, Federico Martinón-Torres, Antonio Salas
Doi:
PLoS ONE
Factor de impacto:
Q2
Doi:
The complete mitogenome of a 500-year-old Inca child mummy
Alberto Gómez-Carballa, Laura Catelli, Jacobo Pardo-Seco, Federico Martinón-Torres, Lutz Roewer, Carlos Vullo & Antonio Salas
Doi:
Scientific Reports
Factor de impacto:
Q1
Doi:
Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis.
María José de Castro, Jacobo Pardo-Seco, and Federico Martinón-Torres
Doi:
Clin Infect Dis
Factor de impacto:
Q1
Doi:
Mitogenomes from The 1000 Genome Project Reveal New Near Eastern Features in Present-Day Tuscans
Alberto Gómez-Carballa1, Jacobo Pardo-Seco, Jorge Amigo, Federico Martinón-Torres, Antonio Salas
Doi:
PLoS ONE
Factor de impacto:
Q2
Doi:
Vacunas antimeningocócicas. Situación epidemiológica mundial y estrategias de prevención mediante la vacunación
Irene Rivero Calle, Carmen Rodriguez-Tenreiro Sánchez, Federico Martinón-Torres
Doi:
Enferm Infecc Microbiol Clin.
Factor de impacto:
Q4
Doi:
Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics.
Natalie I Mazur, Federico Martinón-Torres, Eugenio Baraldi, Brigitte Fauroux, Anne Greenough, Terho Heikkinen, Paolo Manzoni, Asuncion Mejias, Harish Nair, Nikolaos G Papadopoulos, Fernando P Polack, Octavio Ramilo, Mike Sharland, Renato Stein, Shabir A Madhi, Louis Bont, in collaboration with Respiratory Syncytial Virus Network (ReSViNET)
Doi:
Lancet Respir Med
Factor de impacto:
Q1
Doi:
Impact of Rotavirus Vaccination on Childhood Hospitalization for Seizures.
Jacobo Pardo-Seco, Miriam Cebey-López, Nazareth Martinón-Torres, Antonio Salas, José Gómez-Rial, Carmen Rodriguez-Tenreiro, José María Martinón-Sánchez and Federico Martinón-Torres
Doi:
Pediatric Infec Dis J.
Factor de impacto:
Q2
Doi:
A STRATEGY TARGETING MONOCYTE-MACROPHAGE DIFFERENTIATION TO AVOID PULMONARY COMPLICATIONS IN SARS-COV2 INFECTION
J.Gómez-Rial, F.Martinón-Torres
Clin Immunol
Factor de impacto:
Q2
Doi:
MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS
Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas
bioRxiv
Factor de impacto:
Q1
Doi:
CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2
Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)
JAMA
Factor de impacto:
Q1
Doi:
RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS
Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas
International J Molecular Sciences
Factor de impacto:
Q1
Doi:
COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.
Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.
Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .
J Infect Dis.
Factor de impacto:
Q1
Doi:
PROTECTING THE MOST VULNERABLE AGE GROUP: A REVIEW OF MENACWY-TT IMMUNOGENICITY AND SAFETY IN INFANTS.
Martinón-Torres F, Serra L, Safadi MAP.
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
PATHWAY TOWARDS AN IDEAL AND SUSTAINABLE FRAMEWORK AGREEMENT FOR THE PUBLIC PROCUREMENT OF VACCINES IN SPAIN: A MULTI-CRITERIA DECISION ANALYSIS.
Zozaya González N, Alcalá Revilla B, Arrazola Martínez P, Chávarri Bravo JR, Cuesta Esteve I, García Rojas A, Martinón-Torres F, Redondo Margüello E, Rivero Cuadrado A, Tamames Gómez S, Villaseca Carmena J, Hidalgo-Vega A
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
WHOLE-EXOME SEQUENCING FOR THE IDENTIFICATION OF RARE VARIANTS IN PRIMARY IMMUNODEFICIENCY GENES IN CHILDREN WITH SEPSIS - A PROSPECTIVE POPULATION-BASED COHORT STUDY
Alessandro Borghesi, Johannes Trück, Samira Asgari, Vanessa Sancho-Shimizu, Philipp KA Agyeman, Evangelos Bellos, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Sara Bernhard-Stirnemann, Anita Niederer-Loher, Christian R Kahlert, Giancardlo Natalucci, Christa Relly, Thomas Riedel, Claudia E Kuehni, Christian W. Thorball, Nimisha Chaturvedi, Federico Martinon-Torres, Taco W Kuijpers, Lachlan Coin, Victoria Wright, Jethro Herberg, Michael Levin, Christoph Aebi, Christoph Berger, Jacques Fellay, Luregn J Schlapbach, for the EUCLIDS consortium and the Swiss Paediatric Sepsis Study
Clin Infect Dis
Factor de impacto:
Q1
Doi:
Links
Department of pediatricsGenCovidNanostringNextSeq
Legal noticePrivacy policy
Genvip 2023® – All rights reserved